[Results of the use of 3-4-5-trimethoxybenzoyl-epsilon-amino-caproic acid (C-3) in acute phase of myocardial infarct].
D000208:Acute Disease; D000614:Aminocaproates / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000209:etiology; D002037:Bundle-Branch Block / Q000209:etiology; D005117:Cardiac Complexes, Premature / Q000209:etiology; D004341:Drug Evaluation; D004361:Drug Tolerance; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D013610:Tachycardia / Q000209:etiology; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000209:etiology
D000614:Aminocaproates
Risultati dell'impeigo dell'acido 3-4-5-trimetossi-benzoil-epsilon-amino-caproico (C-tre) nell'infarto miocardico in fase acuta.